The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05152472
Brief Title: A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST)

First Submitted : November 26, 2021
First Submitted that Met QC Criteria : November 26, 2021
First Posted : December 9, 2021

Last Update Submitted that Met QC Criteria : July 31, 2023
Last Update Posted : August 1, 2023